Mobile Cognitive Behavioral Therapy for Anxiety and Depression
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Mobile Cognitive Behavioral Therapy for Anxiety and Depression is an effective treatment?
The available research shows that Mobile Cognitive Behavioral Therapy (CBT) is effective for treating anxiety and depression. For example, a study on internet-based CBT programs found that patients with moderate depression experienced a 23% reduction in their depression scores after using the program. Additionally, clinics in several countries reported large improvements in patients' mental health and high satisfaction levels when using internet-delivered CBT. These findings suggest that Mobile CBT can be a valuable tool for managing anxiety and depression, offering a convenient and effective alternative to traditional therapy.12345
What safety data exists for mobile CBT for anxiety and depression?
The safety data for mobile cognitive behavioral therapy (CBT) indicates that when CBT is practiced appropriately, the rate of adverse events is as low as or lower than using a pill placebo. Adverse events are often linked to low-quality CBT due to therapists' lack of knowledge, skills, and experience. Effective CBT requires frequent patient assessments and supervision. Mobile CBT has been shown to be effective for anxiety and depression, with studies indicating large effect sizes in both therapist-led and technology-supported settings.16789
Is Clinician Delivered CBT a promising treatment for anxiety and depression?
What is the purpose of this trial?
This trial tests if adding a mobile app to regular therapy sessions helps young adults with anxiety and depression more than just therapy alone. The app is used to practice therapy exercises, making it easier for patients to manage their symptoms.
Research Team
Patricia Marino
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for medical and graduate students aged 18-40 at Weill Cornell Medicine who are experiencing significant anxiety or depression, as indicated by specific scores on recognized scales. It's not open to those with a history of bipolar or psychotic disorders, or current severe suicidal intentions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive clinician-delivered CBT, with the intervention group also using a mobile app for at least 20 minutes two times per week for six weeks
Follow-up
Participants are monitored for changes in depressive and anxiety symptoms after treatment
Treatment Details
Interventions
- Clinician Delivered CBT
- Supplemental MAYA App
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor